These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8676823)

  • 1. Role of atherogenic lipoproteins in cytokine-mediated renovascular injury.
    Kirschenbaum MA; Pai R; Roh DD; Kamanna VS
    Miner Electrolyte Metab; 1996; 22(1-3):47-50. PubMed ID: 8676823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation.
    Kamanna VS; Pai R; Roh DD; Kirschenbaum MA
    Lab Invest; 1996 Jun; 74(6):1067-79. PubMed ID: 8667611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha stimulates monocyte adhesion to glomerular mesangial cells. The role of intercellular adhesion molecule-1 gene expression and protein kinases.
    Pai R; Bassa B; Kirschenbaum MA; Kamanna VS
    J Immunol; 1996 Apr; 156(7):2571-9. PubMed ID: 8786321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between lipoproteins, glomerular cells and matrix.
    Wheeler DC; Chana RS
    Miner Electrolyte Metab; 1993; 19(3):149-64. PubMed ID: 8232102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
    Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
    Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low density lipoproteins and mitogenic signal transduction processes: role in the pathogenesis of renal disease.
    Kamanna VS
    Histol Histopathol; 2002 Apr; 17(2):497-505. PubMed ID: 11962755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low density lipoproteins transactivate EGF receptor: role in mesangial cell proliferation.
    Kamanna VS; Bassa BV; Ganji SH
    Life Sci; 2008 Oct; 83(17-18):595-601. PubMed ID: 18805430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids and the progression of renal disease.
    Keane WF; O'Donnell MP; Kasiske BL; Schmitz PG
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S69-74. PubMed ID: 16989069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesangial matrix-activated monocytes express functional scavenger receptors and accumulate intracellular lipid.
    Rahman EU; Ruan XZ; Chana RS; Brunskill NJ; Gaya J; Powis SH; Varghese Z; Moorhead JF; Wheeler DC
    Nephrol Dial Transplant; 2008 Jun; 23(6):1876-85. PubMed ID: 18281317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circumferential mesangial interposition: a form of mesangiolysis.
    Nakamoto Y; Yasuda T; Imai H; Miura AB
    Nephrol Dial Transplant; 1992; 7(5):373-8. PubMed ID: 1321370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the effects of cytokines on the expression of adhesion molecules in endothelial cells.
    Okada M; Matsuto T; Miida T; Inano K
    Ann Med Interne (Paris); 1997; 148(2):125-9. PubMed ID: 9238436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of mesangial injury in glomerular diseases.
    Daha MR
    J Nephrol; 2000; 13 Suppl 3():S89-95. PubMed ID: 11132039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Huoxue injection on oxidized low-density lipoprotein induced activation of human umbilical vein endothelial cells].
    Zhu LQ; Wang SR; Zhao MJ; Cui W; Niu FL
    Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(13):1617-21. PubMed ID: 18837329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression.
    Lafrenie RM; Wahl LM; Epstein JS; Yamada KM; Dhawan S
    J Immunol; 1997 Oct; 159(8):4077-83. PubMed ID: 9378998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renal toxicity of sustained glomerular protein traffic.
    Benigni A; Zoja C; Remuzzi G
    Lab Invest; 1995 Oct; 73(4):461-8. PubMed ID: 7474916
    [No Abstract]   [Full Text] [Related]  

  • 18. CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms.
    Kuroiwa T; Lee EG; Danning CL; Illei GG; McInnes IB; Boumpas DT
    J Immunol; 1999 Aug; 163(4):2168-75. PubMed ID: 10438958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
    Capobianchi MR
    J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
    Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
    Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.